Flamingo Therapeutics
Gaston Geenslaan 1
3001 Leuven
BE
Flamingo Therapeutics
Foundation date
04/07/2019
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
The core business of Flamingo Therapeutics is the development of novel and innovative drugs for specific cancer types.Upcoming events
All events-
2809 '22
NLSDays 2022
Event by: SwedenBIO -
2405 '22
PrecisionMed Expo & Summit
Event by: Smart Planet Media International -
2405 '22
EMERGE GHI
Event by: Smart Planet Media International
Latest news
More news-
Latest field trials validate strength of Biotalys’ first biocontrol Evoca
Thursday May 19th 2022
Read more
-
Belgian biotech in European Top-3 despite turbulent times
Wednesday May 18th 2022
Read more
-
KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus
Wednesday May 18th 2022
Read more